G. Caratù

发表

Early evolutionary divergence between papillary and anaplastic thyroid cancers

J. Tabernero, P. Nuciforo, J. Tabernero, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

Rodrigo Dienstmann, Jordi Rodon, Josep Tabernero, 2015, Clinical Cancer Research.

FixNCut: Single-cell genomics through reversible tissue fixation and dissociation

P. Rosenstiel, M. Nawijn, H. Heyn, 2023, bioRxiv.

An atlas of cells in the human tonsil

E. Campo, F. Prósper, J. Martín-Subero, 2022, bioRxiv.

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

R. Salazar, P. Nuciforo, J. Tabernero, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer

R. Dienstmann, T. Troiani, I. Puig, 2023, ESMO open.

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

R. Salazar, Cristina Santos, J. Tabernero, 2019, Molecular oncology.

Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.

F. Mancuso, A. Vivancos, J. Hernández-Losa, 2017, The Journal of investigative dermatology.

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

P. Kristel, C. Caldas, O. Rueda, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings

F. Mancuso, S. Bonache, O. Díez, 2018, Journal of Cancer Research and Clinical Oncology.

Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer

E. Felip, S. Cedrés, P. Nuciforo, 2021, British Journal of Cancer.

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma

X. Puente, C. Rubio-Perez, M. Poca, 2020, Nature Communications.

Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway

A. Vivancos, J. Hernández-Losa, J. Cortés, 2016, Oncotarget.

Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations

A. Vivancos, J. Hernández-Losa, D. Bodet, 2016, Pigment cell & melanoma research.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

P. Nuciforo, J. Tabernero, J. Seoane, 2019, Annals of Oncology.

Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy

G. Stassi, H. Heyn, S. Tejpar, 2022, Nature Cancer.

TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence

J. Tabernero, P. Nuciforo, R. Dienstmann, 2018, The Journal of clinical investigation.

Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk

F. Rodríguez, M. Salas, J. Argilaguet, 2022, PLoS pathogens.

Identification of the Ligands of Protein Interaction Domains through a Functional Approach*S

A. Scaloni, T. Russo, N. Zambrano, 2007, Molecular & Cellular Proteomics.

Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease

Helena L. Crowell, H. Heyn, Á. Corbí, 2022, bioRxiv.

Identification of colorectal cancer cells that mediate relapse after chemotherapy by marker gene Mex3a

Camille Stephan-Otto Attolini, H. Heyn, S. Tejpar, 2022 .

Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease

Helena L. Crowell, H. Heyn, Á. Corbí, 2023, Nature communications.

Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas

M. Esteller, J. Tabernero, F. Mancuso, 2019, Clinical Cancer Research.

Abstract P4-07-05: PARP inhibition in breast and ovarian patient-derived tumor xenografts (PDX) harboring germline BRCA1/2 mutations unveils mechanisms of primary and acquired resistance that restore homologous recombination (HR)

C. Caldas, J. Baselga, J. Cortes, 2016 .

Inhibition of PID1/NYGGF4/PCLI1 gene expression highlights its role in the early events of the cell cycle in NIH3T3 fibroblasts

A. Scaloni, N. Zambrano, F. Napolitano, 2016, Journal of enzyme inhibition and medicinal chemistry.

Systematic benchmarking of single-cell ATAC-sequencing protocols

Andrew C. Adey, Jason D. Buenrostro, Fabiana M. Duarte, 2023, Nature biotechnology.

Interpretable Inflammation Landscape of Circulating Immune cells

P. Vandergheynst, A. Villani, M. Nawijn, 2023, bioRxiv.

Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation.

X. Puente, J. Baselga, E. Felip, 2013, Cancer discovery.